TG Therapeutics | TGTX - PE Price to Earnings


TG Therapeutics reported 10.76 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
AbbVie 24.03 86.23 Dec/2025
Amgen 25.31 15.82 Dec/2025
Bayer 5.93 0.68 Sep/2025
Biogen 14.02 4.63 Dec/2025
Corcept Therapeutics 41.9 52.28 Dec/2025
Gilead Sciences 15.63 0.08 Dec/2025
J&J 23.62 0.86 Dec/2025
Novartis 17.85 2.11 Dec/2025
Novavax 2.01 1.07 Dec/2025
PTC Therapeutics 9.98 3.25 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
TG Therapeutics 10.76 2.32 Dec/2025
Vertex Pharmaceuticals 26.15 2.22 Dec/2025